Skip to main content
Top
Published in: Respiratory Research 1/2006

Open Access 01-12-2006 | Research

Prenatal and postnatal tobacco smoke exposure and respiratory health in Russian children

Authors: Jouni JK Jaakkola, Anna A Kosheleva, Boris A Katsnelson, Sergey V Kuzmin, Larissa I Privalova, John D Spengler

Published in: Respiratory Research | Issue 1/2006

Login to get access

Abstract

Background

Only few studies have assessed the relative impact of prenatal and postnatal exposure to tobacco smoke on the child's later asthma or chronic respiratory symptoms and to our knowledge no studies have elaborated respiratory infections and allergies in this context.

Objective

To assess the effects of prenatal and postnatal exposure to tobacco smoke on respiratory health of Russian school children.

Methods

We studied a population of 5951 children (8 to12 years old) from 9 Russian cities, whose parents answered a questionnaire on their children's respiratory health, home environment, and housing characteristics. The main health outcomes were asthma, allergies, chronic respiratory symptoms, chronic bronchitis, and upper respiratory infections. We used adjusted odds ratios (ORs) from logistic regression analyses as measures of effect.

Results

Prenatal exposure due to maternal smoking had the strongest effects on asthma (adjusted OR 2.46, 95% CI 1.19–5.08), chronic bronchitis (adjusted OR 1.45, 95% CI 1.08–1.96) and respiratory symptoms, such as wheezing (adjusted OR 1.30, 95% CI 0.90–1.89). The associations were weaker for exposure during early-life (adjusted ORs 1.38/1.27/1.15 respectively) and after 2 years of age (adjusted ORs 1.45/1.34/1.18) compared to prenatal exposure and the weakest or non-existent for current exposure (adjusted ORs 1.05/1.09/1.06). Upper respiratory infections were associated more strongly with early-life exposure (adjusted OR 1.25, 95% CI 1.09–1.42) than with prenatal (adjusted OR 0.74, 95% CI 0.54–1.01) or current exposure (adjusted OR1.05, 95% CI 0.92–1.20). The risk of allergies was also related to early life exposure to tobacco smoke (adjusted OR 1.26, 95% CI 1.13–1.42).

Conclusion

Adverse effects of tobacco smoke on asthma, chronic bronchitis, and chronic respiratory symptoms are strongest when smoking takes place during pregnancy. The relations are weaker for exposure during early-life and after 2 years of age and weakest or non-existent for current exposure.
Literature
1.
go back to reference Kramer MS: Determinants of low birth weight: methodological assessment and meta-analysis. Bulletin of the World Health Organization 1987, 65:663–737.PubMedPubMedCentral Kramer MS: Determinants of low birth weight: methodological assessment and meta-analysis. Bulletin of the World Health Organization 1987, 65:663–737.PubMedPubMedCentral
2.
go back to reference Stick SM, Burton PR, Gurrin L, Sly PD, LeSouef PN: Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996, 348:1060–1064.CrossRefPubMed Stick SM, Burton PR, Gurrin L, Sly PD, LeSouef PN: Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996, 348:1060–1064.CrossRefPubMed
3.
go back to reference Lødrup Carlsen KC, Jaakkola JJK, Nafstad P, Carlsen KH: In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J 1997, 10:1774–1779.CrossRefPubMed Lødrup Carlsen KC, Jaakkola JJK, Nafstad P, Carlsen KH: In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J 1997, 10:1774–1779.CrossRefPubMed
4.
go back to reference Hoo AF, Henschen M, Dezateux C, Costeloe K, Stocks J: Respiratory function among preterm infants whose mother smoked during pregnancy. Am J Respir Crit Care Med 1998, 158:700–705.CrossRefPubMed Hoo AF, Henschen M, Dezateux C, Costeloe K, Stocks J: Respiratory function among preterm infants whose mother smoked during pregnancy. Am J Respir Crit Care Med 1998, 158:700–705.CrossRefPubMed
5.
go back to reference Milner AD, Marsh MJ, Ingram DM, Fox GF, Susiva C: Effects of smoking in pregnancy and neonatal lung function. Arch Dis Child Fetal Neonatal Ed 1999, 80:F8–14.CrossRefPubMedPubMedCentral Milner AD, Marsh MJ, Ingram DM, Fox GF, Susiva C: Effects of smoking in pregnancy and neonatal lung function. Arch Dis Child Fetal Neonatal Ed 1999, 80:F8–14.CrossRefPubMedPubMedCentral
6.
go back to reference Hanrahan JP, Tager IB, Segal MR, Tosteson TD, Castile RCT, Van Vunakis H, Weiss ST, Speizer FE: The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis 1992, 145:1129–1135.CrossRefPubMed Hanrahan JP, Tager IB, Segal MR, Tosteson TD, Castile RCT, Van Vunakis H, Weiss ST, Speizer FE: The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis 1992, 145:1129–1135.CrossRefPubMed
7.
go back to reference Young S, Le Souef PN, Geelhoed GC, Stick STM, Chir B, Turner KJ, Landau LI: The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med 1991, 324:1168–1173.CrossRefPubMed Young S, Le Souef PN, Geelhoed GC, Stick STM, Chir B, Turner KJ, Landau LI: The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med 1991, 324:1168–1173.CrossRefPubMed
8.
go back to reference Jaakkola JJK, Jaakkola MS: Effects of environmental tobacco smoke on the respiratory health of children. Scand J Work Environ Health 2002,28(Suppl 2):71–83.PubMed Jaakkola JJK, Jaakkola MS: Effects of environmental tobacco smoke on the respiratory health of children. Scand J Work Environ Health 2002,28(Suppl 2):71–83.PubMed
10.
go back to reference Gilliland FD, Li YF, Peters JM: Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 2001, 163:429–36.CrossRefPubMed Gilliland FD, Li YF, Peters JM: Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 2001, 163:429–36.CrossRefPubMed
11.
go back to reference Cunningham J, O'Connor GT, Dockery DW, Speizer FE: Environmental tobacco smoke, wheezing, and asthma in children in 24 communities. Am J Respir Crit Care Med 1996, 153:218–224.CrossRefPubMed Cunningham J, O'Connor GT, Dockery DW, Speizer FE: Environmental tobacco smoke, wheezing, and asthma in children in 24 communities. Am J Respir Crit Care Med 1996, 153:218–224.CrossRefPubMed
12.
go back to reference Lux AL, Henderson AJ, Pocock SJ, the ALSPAC Study Team: Wheezing associated with prenatal tobacco smoke exposure: a procpective, longitudinal study. Arch Dis Child 2000, 83:307–12.CrossRefPubMedPubMedCentral Lux AL, Henderson AJ, Pocock SJ, the ALSPAC Study Team: Wheezing associated with prenatal tobacco smoke exposure: a procpective, longitudinal study. Arch Dis Child 2000, 83:307–12.CrossRefPubMedPubMedCentral
13.
go back to reference Jaakkola JJ, Cherniack M, Spengler JD, Ozkaynak H, Wojtyniak B, Egorov A, et al.: Use of health information systems in the Russian Federation in the assessment of environmental health effects. Environ Health Perspect 2000, 108:589–594.CrossRefPubMedPubMedCentral Jaakkola JJ, Cherniack M, Spengler JD, Ozkaynak H, Wojtyniak B, Egorov A, et al.: Use of health information systems in the Russian Federation in the assessment of environmental health effects. Environ Health Perspect 2000, 108:589–594.CrossRefPubMedPubMedCentral
14.
go back to reference Ferris BG: Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978,118(6 pt 2):1–120.PubMed Ferris BG: Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978,118(6 pt 2):1–120.PubMed
15.
go back to reference Jaakkola JJK, Jaakkola N, Ruotsalainen R: Home dampness and molds as determinants of respiratory symptoms and asthma in pre-school children. J Expo Anal Environ Epidemiol 1993,3(Suppl 1):129–42.PubMed Jaakkola JJK, Jaakkola N, Ruotsalainen R: Home dampness and molds as determinants of respiratory symptoms and asthma in pre-school children. J Expo Anal Environ Epidemiol 1993,3(Suppl 1):129–42.PubMed
16.
go back to reference Privalova LI, Katsnelson BA, Kuzmin SV, Nikonov BI, Gurvich VB, Kosheleva AA, Malykh OL, Voronin SA: Environmental Epidemiology: Principles, Methods, Applications. Ekaterinburg: Medical Research Center for Prophylaxis; 2003. Privalova LI, Katsnelson BA, Kuzmin SV, Nikonov BI, Gurvich VB, Kosheleva AA, Malykh OL, Voronin SA: Environmental Epidemiology: Principles, Methods, Applications. Ekaterinburg: Medical Research Center for Prophylaxis; 2003.
17.
go back to reference Tager IB: Smoking and childhood asthma-where do we stand? Am J Respir Crit Care Med 1998, 158:349–351.CrossRefPubMed Tager IB: Smoking and childhood asthma-where do we stand? Am J Respir Crit Care Med 1998, 158:349–351.CrossRefPubMed
18.
19.
go back to reference Søyseth V, Kongerud J, Boe J: Postnatal maternal smoking increases the prevalence of asthma but not of bronchial hyperresponsiveness or atopy in their children. Chest 1995, 107:389–394.CrossRefPubMed Søyseth V, Kongerud J, Boe J: Postnatal maternal smoking increases the prevalence of asthma but not of bronchial hyperresponsiveness or atopy in their children. Chest 1995, 107:389–394.CrossRefPubMed
Metadata
Title
Prenatal and postnatal tobacco smoke exposure and respiratory health in Russian children
Authors
Jouni JK Jaakkola
Anna A Kosheleva
Boris A Katsnelson
Sergey V Kuzmin
Larissa I Privalova
John D Spengler
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2006
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-7-48

Other articles of this Issue 1/2006

Respiratory Research 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.